$17.51
1.57% today
NYSE, Feb 05, 04:20 pm CET
ISIN
NL0000200384
Symbol
CLB

Core Laboratories NV Stock price

$17.24
-1.32 7.11% 1M
-3.66 17.51% 6M
-0.07 0.40% YTD
+2.32 15.55% 1Y
-9.78 36.20% 3Y
-19.16 52.64% 5Y
-86.06 83.31% 10Y
NYSE, Closing price Tue, Feb 04 2025
+0.69 4.17%
ISIN
NL0000200384
Symbol
CLB
Sector

Key metrics

Market capitalization $809.42m
Enterprise Value $970.40m
P/E (TTM) P/E ratio 26.54
EV/FCF (TTM) EV/FCF 22.69
EV/Sales (TTM) EV/Sales 1.85
P/S ratio (TTM) P/S ratio 1.55
P/B ratio (TTM) P/B ratio 3.23
Dividend yield 0.23%
Last dividend (FY24) $0.04
Revenue growth (TTM) Revenue growth 2.76%
Revenue (TTM) Revenue $523.85m
EBIT (operating result TTM) EBIT $48.60m
Free Cash Flow (TTM) Free Cash Flow $42.76m
Cash position $19.16m
P/E forward 17.33
P/S forward 1.51
EV/Sales forward 1.81
Short interest 25.54%
Show more

Is Core Laboratories NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Core Laboratories NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Core Laboratories NV forecast:

2x Hold
40%
3x Sell
60%

Analyst Opinions

5 Analysts have issued a Core Laboratories NV forecast:

Hold
40%
Sell
60%

Financial data from Core Laboratories NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
524 524
3% 3%
100%
- Direct Costs 435 435
5% 5%
83%
88 88
6% 6%
17%
- Selling and Administrative Expenses 25 25
1% 1%
5%
- Research and Development Expense - -
-
-
64 64
10% 10%
12%
- Depreciation and Amortization 15 15
5% 5%
3%
EBIT (Operating Income) EBIT 49 49
11% 11%
9%
Net Profit 31 31
23% 23%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Core Laboratories NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Core Laboratories NV Stock News

Neutral
Seeking Alpha
6 days ago
Core Laboratories Inc. (NYSE:CLB ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Chris Hill - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel Josh Jayne - Daniel Energy Partners David Smith - Pickering Energy Partn...
Neutral
PRNewsWire
7 days ago
FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEAR FOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12%  FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16...
Neutral
PRNewsWire
about one month ago
HOUSTON , Jan. 3, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its fourth quarter 2024 conference call for investors and analysts at 7:30 a.m. CST / 8:30 a.m.
More Core Laboratories NV News

Company Profile

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.

Head office Netherlands
CEO Lawrence Bruno
Founded 2012
Website www.corelab.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today